Back to company

Chosa ApS: Financial statements 2023

CVR: 43134477

Chosa ApS (CVR 43134477) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -1,542,553 and a net result of DKK -2,069,955. Equity amounted to DKK 8,991,145. The solvency ratio was 87.3%.

Gross Profit
-1,542,553 kr.
Profit/Loss
-2,069,955 kr.
Equity
8,991,145 kr.
Total Assets
10,294,826 kr.
Employees
0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Chosa ApS publishes interim reportMar 22, 2023

Chosa ApS has published its interim report for the period March 18, 2022 – December 31, 2022.

Registered as owner of Chosa ApSJan 18, 2023

As of January 18, 2023, is registered as an owner of Chosa ApS with an ownership share of 100%.

About Chosa ApS

Chosa ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2022. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Claus Frisenberg Pedersen and Peter Buhl. The company is owned by Chosa Oncology AB. In 2025, the company reported a gross profit of DKK -2,136,143 and a net result of DKK -2,632,024 compared with DKK -3,586,839 the year before. Equity amounted to DKK 5,175,030.

Other financial years